An open labelled assessment of adverse effects associated with interferon 1-beta in the treatment of multiple sclerosis.
Ozuma
J
J
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010349:Patient Compliance
D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a